Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX(R) (Varenicline) Compared With Placebo
November 6, 2009 by admin
Filed under Best Way To Quit Smoking, Quit Smoking Information
New study results showed that 42.3 percent of smokers with mild-to-moderate chronic obstructive pulmonary disease (COPD) who took CHANTIX/CHAMPIX® (varenicline) were able to quit smoking and remain abstinent during the last four weeks of treatment (weeks 9-12) compared with 8.8 percent of those given placebo (p
Buy Chantix
Buy Chantix direct from a registered US pharmacy. Free online consultation.
Related posts:
- Around One In Five Pregnant Smokers Go Undetected Each Year Self-reported smoking during pregnancy underestimates the true number of pregnant...
- Cigarettes Seem Less Attractive To Smokers Following Exercise Exercise can help smokers quit because it makes cigarettes less...
- Adult Smoking Drops Again, Saving Lives And $2.8 Billion In Future Health Care Costs Washington’s adult smoking rate has hit a new low for...
- Dendritic Cells Spark Smoldering Inflammation In Smokers’ Lungs Inflammation still ravages the lungs of some smokers years after...
- Most Smokers Make Multiple Quit Attempts Before They Quit Smoking For Good The American Lung Association is launching a new smoking cessation...
